References
- 1. Beghi E, Giussani G, Sander JW. The natural history and prognosis of epilepsy. Epileptic Disord. 2015;17(3):243–53.10.1684/epd.2015.0751
- 2. Sander JW. The epidemiology of epilepsy rivisited. Curr Opin Neurol. 2008;16:165–70.10.1097/00019052-200304000-00008
- 3. Berghi E. Prognosis of first seizure. In: Jallon P, Berg AT, Dulac O, Hauser WA. Prognosis of epilepsies. Montrouge: JohnLibbey; 2003:21–8.
- 4. Pavlova M. Sudden unexpected death in epilepsy: Assessing the risk factors. Neurology. 2020 28;94(4):e436–e438.10.1212/WNL.0000000000008928
- 5. Manford M. Recent advances in epilepsy. J Neurol. 2017;264(8): 1811–24.10.1007/s00415-017-8394-2
- 6. Haas HL, Sergeeva OA, Selbach O. Histamine in the nervous system. Physiol Rev. 2008;88(3):1183–241.10.1152/physrev.00043.2007
- 7. Hu W, Chen Z. The roles of histamine and its receptor ligands in central nervous system disorders: An update. Pharmacol Ther. 2017;175:116–32.10.1016/j.pharmthera.2017.02.039
- 8. Schlicker E, Kathmann M. Role of the histamine H3 receptor in the central nervous system. Handb Exp Pharmacol. 2017;241:277–99.10.1007/164_2016_12
- 9. Lebois EP, Jones CK, Lindsley CW. The evolution of histamine H3 antagonists/inverse agonists. Curr Top Med Chem. 2011;11(6):648–60.10.2174/1568026611109060648
- 10. Sakai N, Onodera K, Maeyama K, Yanai K, Watanabe T. Effects of thioperamide, a histamine H3 receptor antagonist, on locomotor activity and brain histamine content in mast cell-deficient W/Wv mice. Life Sci. 1991;48(25):2397–404.10.1016/0024-3205(91)90373-J
- 11. Mohsen A, Yoshikawa T, Miura Y, Nakamura T, Naganuma F, Shibuya K, et al. Mechanism of the histamine H(3) receptor-mediated increase in exploratory locomotor activity and anxiety-like behaviours in mice. Neuropharmacol. 2014;81:188–94.10.1016/j.neuropharm.2014.02.00324530460
- 12. Gerald MC, Richter NA. Studies on the effects of histaminergic agents on seizure susceptibility in mice. Psychopharmacol. 1976; 46(3):277–82.10.1007/BF00421114
- 13. Tuomisto L, Tacke U. Is histamine an anticonvulsive inhibitory transmitter? Neuropharmacol. 1986;25(8):955–8.10.1016/0028-3908(86)90029-8
- 14. Yokoyama H, Onodera K, Maeyama K, Yanai K, Iinuma K, Tuomisto L, Watanabe T. Histamine levels and clonic convulsions of electrically-induced seizure in mice: the effects of alpha-fluoromethylhistidine and metoprine. Naunyn Schmiedebergs Arch Pharmacol. 1992;346(1):40–5.10.1007/BF00167568
- 15. Yokoyama H, Onodera K, Iinuma K, Watanabe T. Effect of thioperamide, a histamine H3 receptor antagonist, on electrically induced convulsions in mice. Eur J Pharmacol. 1993;234(1):129–33.10.1016/0014-2999(93)90717-V
- 16. Wyngaarden JB, Seevers MH. The toxic effects of antihistaminic drugs. J Am Med Assoc. 1951;145(5):277–82.10.1001/jama.1951.02920230001001
- 17. Churchill JA, Gammon GD. The effect of antihistaminic drugs on convulsive seizures. J Am Med Assoc. 1949;141(1):18–21.10.1001/jama.1949.02910010020004
- 18. Yokoyama H, Onodera K, Iinuma K, Watanabe T. 2-Thiazolylethylamine, a selective histamine H1 agonist, decreases seizure susceptibility in mice. Pharmacol Biochem Behav. 1994;47(3):503–7.10.1016/0091-3057(94)90151-1
- 19. Yasuhara A, Ochi A, Harada Y, Kobayashi Y. Infantile spasms associated with a histamine H1 antagonist. Neuropediatrics. 1998; 29(6):320–1.10.1055/s-2007-973585
- 20. Yokoyama H, Iinuma K, Yanai K, Watanabe T, Sakurai E, Onodera K. Proconvulsant effect of ketotifen, a histamine H1 antagonist, confirmed by the use of d-chlorpheniramine with monitoring electroencephalography. Methods Find Exp Clin Pharmacol. 1993; 15(3):183–8.
- 21. Świąder M, Wielosz M, Czuczwar SJ. Influence of antazoline and ketotifen on the anticonvulsant activity of conventional antiepileptics against maximal electroshock in mice. Eur Neuropsychopharmacol. 2004;14(4):307–18.10.1016/j.euroneuro.2003.09.005
- 22. Świąder M, Wielosz M, Czuczwar SJ. Interaction of astemizole, an H1 receptor antagonist, with conventional antiepileptic drugs in mice. Pharmacol Biochem Behav. 2003;76(1):169–78.10.1016/S0091-3057(03)00212-0
- 23. Luszczki JJ, Andres MM, Swiader MJ. Effect of lamotrigine combined with felbamate on the horizontal (ambulatory) activity in mice. Ann Univ Mariae Curie Sklodowska Med. 2004;59(2):235–40.
- 24. Ten Eick AP, Blumer JL, Reed MD. Safety of antihistamines in children. Drug Safety. 2001;24(2):119–147.10.2165/00002018-200124020-0000311235817
- 25. Blain PG, Lane RJM. Neurological disorders. In: DM. Davies, RE. Ferner, H. De Glanville (eds). Davies’s Textbook of Adverse Drug Reactions. 5th ed. London: Chapman and Hall Medical; 1998:591–3.
- 26. Murphy K, Delanty N. Drug-induced seizures: general principles in assessment, management and prevention. CNS Drugs, 2000;14(2): 135–46.10.2165/00023210-200014020-00004
- 27. Świąder M, Świąder K. Influence of astemizole, an H1 receptor antagonist, on the locomotors activity of carbamazepine and valproate in mice. Curr Issues Pharm Med Sci. 2012;25(2):173–5.10.12923/j.2084-980X/25.2/a.13
- 28. Tuomisto J, Tuomisto L. Effects of histamine and histamine antagonists on the uptake and release of catecholamines and 5-HT in brain synaptosomes. Med Biol. 1980;58(1):33–7.
- 29. Miyazaki S, Imaizumi M, Onodera K. Effects of thioperamide on the cholinergic system and the step-throuhg passive avoidance test in mice. Methods Find Exp Clin Pharmacol. 1995;17(10):653–8.
- 30. Provensi G, Costa A, Passani MB, Blandina P. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse. Neuropharmacol. 2016;109:139–47.10.1016/j.neuropharm.2016.06.01027291828
- 31. Bitner RS, Markosyan S, Nikkel AL, Brioni JD. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer’s disease. Neuropharmacol. 2011;60(2–3):460–6.10.1016/j.neuropharm.2010.10.02621044639
- 32. Serafim KR, Kishi MS, Canto-de-Souza A, Mattioli R. H1 but not H2 histamine antagonist receptors mediate anxiety-related behaviors and emotional memory deficit in mice subjected to elevated plus-maze testing. Braz J Med Biol Res. 2013;46(5):440–6.10.1590/1414-431X20132770385439823598647
- 33. Serafim KR, Gianlorenço AC, Daher FP, Mattioli R. H1-histamine receptors in the amygdala are involved in emotional memory but do not mediate anxiety-related behaviors in mice submitted to EPM testing. Brain Res Bull. 2012;89(1–2):1–7.10.1016/j.brainresbull.2012.06.00922772356